EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system

Quentin Samaran, Thomas Bettuzzi, Emilie Sbidian

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116585 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Quentin Samaran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department …. Hauptthemen laut MEDLINE: Cetuximab, Cutaneous Squamous Cell Carcinoma, Skin Neoplasms, Immune Checkpoint Inhibitors. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CHU de Montpellier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CetuximabCutaneous Squamous Cell CarcinomaSkin NeoplasmsImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorAntineoplastic Agents, ImmunologicalHumansFemaleAgedMaleFranceRetrospective StudiesMiddle AgedAged, 80 and overAntibodies, Monoclonal, HumanizedAdultNivolumabProgression-Free SurvivalAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Anti-PD-1CetuximabCutaneous squamous cell carcinomaDatabaseImmune checkpoint inhibitorsSNDSSkin neoplasms

Substanzen

CetuximabImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalNivolumabPDCD1 protein, humanpembrolizumabcemiplimab

Autor:innen und Institutionen

  • Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Montpellier University Hospital, Montpellier, France;…
  • Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Henri Mondor Hospital, Créteil, France.
  • Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE) EA7379, University Paris-Est Créteil Val de Marne, Créteil, France; Department of Dermatology, Henri Mondor Hospital, Créteil, France; Clinical Inves…

Förderung

  • CHU de Montpellier

Zitieren

APA

Samaran, Q., Bettuzzi, T., & Sbidian, E. (2026). Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116585

Vancouver

Samaran Q, Bettuzzi T, Sbidian E. Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116585

BibTeX
@article{Samaran2026,
  author = {Samaran, Quentin and Bettuzzi, Thomas and Sbidian, Emilie},
  title = {Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116585}
}
Kostenlos starten →